drugset / Trial / NCT01740609
A Study To Assess The Safety Of PF-06342674 In Healthy Volunteers
RandomizedParallel-groupDouble-blindBasic science
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetics and immunogenicity of single escalating doses PF-06342674.
Timeline
- Start
- 2012-11
- Primary completion
- 2014-06
- Completion
- 2014-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | PF-06342674 | Unknown | — | Subcutaneous |
Indications
No indication recorded.